In a new report on AR, it calls for more innovation and research in vaccines as one of the ways to tackle the problem.

Resistant hospital-onset infections and deaths both increased at least 15% in the US during the first year of the pandemic.

More than 29,400 people died from antimicrobial-resistant infections commonly associated with healthcare.

Increases in specific pathogens included:

  • carbapenem-resistant Acinetobacter ​– 78% increase in infections
  • multidrug-resistant Pseudomonas aeruginosa ​– 32% increase
  • vancomycin-resistant Enterococcus​ (VRE) – 14% increase
  • methicillin-resistant Staphylococcus aureus​ (MRSA) – 13% increase

Of these, nearly 40% got the infection while they were in the hospital (the total national burden of deaths from AR may be much higher, says the CDC, but data gaps caused by the pandemic hinder that analysis).

“This setback can and must be temporary. The COVID-19 pandemic has unmistakably shown us that antimicrobial resistance will not stop if we let down our guard; there is no time to waste,”​ said Michael Craig, MPP, Director of CDC’s Antibiotic Resistance Coordination & Strategy Unit.

“The best way to avert a pandemic caused by an antimicrobial-resistant pathogen is to identify gaps and invest in prevention to keep our nation safe.”


By admin

Leave a Reply

Your email address will not be published. Required fields are marked *